Facing an expected sharp drop in sales, Pfizer (PFE) says it's open to growing revenue by...


Facing an expected sharp drop in sales, Pfizer (PFE) says it's open to growing revenue by acquiring a large rival. Its mega-merger comments buck the current industry trend of small partnerships and could drive a new wave of consolidation.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs